detected 2026-09-11 no amending act named
02006R1907-20260511 → 02006R1907-20260622
in force not stated
1 provision touched — 1 substantive, 0 date-only, 0 with no text, 0 disputed · 1 change without an explanation
No amending act is named for this event: the EU's own amendment metadata annotated nothing in this window and there were no amending-act instructions to read, so only the text comparison observed it. That is a fact about the corpus's records for the window, not a doubt about the text shown below.
MODIFIED +477 −358 Annex XVII RESTRICTIONS ON THE MANUFACTURE, PLACING ON THE MARKET AND USE OF CERTAIN DANGEROUS SUBSTANCES, MIXTURES AND ARTICLES§
applies from: unchanged
No explanation shipped — the difference between the two versions lies beyond the characters this stage can show, so no explanation was requested.
text before / after
02006R1907-20260511 → 02006R1907-20260622
compared line by line: this provision is too large to compare word by word, so a marked line is a line that changed somewhere
ANNEX XVII
RESTRICTIONS ON THE MANUFACTURE, PLACING ON THE MARKET AND USE OF CERTAIN DANGEROUS SUBSTANCES, MIXTURES AND ARTICLES
For substances which have been incorporated in this Annex as a consequence of restrictions adopted in the framework of Directive 76/769/EEC (Entries 1 to 58), the restrictions shall not apply to storage, keeping, treatment, filling into containers, or transfer from one container to another of these substances for export, unless the manufacture of the substances is prohibited.
… 1,275 unchanged lines …
(b) 0,3 μm in length, for particles that have a length that is equal to or smaller than 15 mm and a length to diameter ratio greater than 3.
4. Paragraph 1 shall not apply to the placing on the market of:
(a) synthetic polymer microparticles on their own or in mixtures, for use at industrial sites;
(b) medicinal products within the scope of Directive 2001/83/EC and veterinary medicinal products within the scope of Regulation (EU) 2019/6 of the European Parliament and of the Council (b) medicinal products as defined by Directive 2001/83/EC or veterinary medicinal products as defined by Regulation (EU) 2019/6
;
(c) EU fertilising products within the scope of Regulation (EU) 2019/1009 of the European Parliament and of the Council
;
(d) food additives within the scope of Regulation (EC) No 1333/2008 of the European Parliament and of the Council
;
(e) in vitro diagnostic devices, including devices within the scope of Regulation (EU) 2017/746 of the European Parliament and of the Council
;
(f) food within the meaning of Article 2 of Regulation (EC) No 178/2002, not covered by point (d) of this paragraph, and feed as defined in Article 3(4) of that Regulation. (f) food within the meaning of Article 2 of Regulation (EC) No 178/2002, not covered by point (d) of this paragraph, and feed as defined in Article 3(4) of that Regulation;
(g) synthetic polymer microparticles, on their own or in mixtures, for use in product and process orientated research and development, in quantities of 1 tonne per year or less.
5. Paragraph 1 shall not apply to the placing on the market of the following synthetic polymer microparticles on their own or in mixtures:
(a) synthetic polymer microparticles which are contained by technical means so that releases to the environment are prevented when used in accordance with the instructions for use during the intended end use;
(b) synthetic polymer microparticles the physical properties of which are permanently modified during intended end use in such a way that the polymer no longer falls within the scope of this entry;
… 3,476 unchanged lines …
Loading: 10 g/1000 mL
Test time: 24 h
Pass criterion: solubility > 2 g/L.
The full entry, with the citation mapping v1 = 02006R1907-20260511, v2 = 02006R1907-20260622, is committed at eu/32006R1907/CHANGELOG.md.